| |
| |
|
| Insider
Information: |
Carruthers R Michael |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
59,230 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,551,360 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
59,230 |
|
|
| Total
Value |
$1,551,360 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alpine Immune Sciences Inc |
ALPN |
Exec Vice President / ... |
2016-12-02 |
24,000 |
2016-12-02 |
0 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
|
2024-05-02 |
35,230 |
2022-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2024-05-02 |
4 |
S |
$18.91 |
$40,789 |
D/D |
(2,157) |
35,230 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
37,387 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2024-01-23 |
4 |
OE |
$1.93 |
$173,700 |
D/D |
90,000 |
119,024 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2024-01-23 |
4 |
AS |
$15.78 |
$1,419,759 |
D/D |
(90,000) |
29,024 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2023-06-22 |
4 |
OE |
$0.71 |
$7,100 |
D/D |
10,000 |
29,024 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2023-05-02 |
4 |
S |
$8.90 |
$11,897 |
D/D |
(1,336) |
16,126 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2023-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
17,462 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Financial Officer |
• – – |
2022-05-23 |
4 |
OE |
$0.71 |
$6,390 |
D/D |
9,000 |
12,000 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President / CFO |
• – – |
2016-12-02 |
4 |
B |
$2.09 |
$50,256 |
D/D |
24,000 |
24,000 |
2.74 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
